Escherichia coli strain Nissle 1917 (Mutaflor®,) enteric coated hard capsule finished product (probiotic)

Escherichia coli strain Nissle 1917  (Mutaflor®,)  enteric coated hard capsule finished product (probiotic)
Product Description

E. coli strain Nissle 1917 is of human origin. It fulfills all microbiological and molecular biological safety requirements.
In the field of gastgroenterology it is

  • used maintain the remission stage of ulcerative colitis
  • and to treat patients with chronic constipation.

The product quality is amongs others, characterized by its microbiological purity and the defined high number of viable cell in each chard capsule.
The pharmaceutical form of a enteric coated hard caplsule allows, that high numbers of E. coli Nissle bacteria can reach the intestinal tract in a viable state.
CTD is available.

Live Biotherapeutic Product (LBP)

Pharma Zentrale GmbH

  • DE
  • 2015
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
Specifications
  • Selling Points
    Digestive Health; Price; Product Features; Quality Service
  • Supplied from
    Germany
  • Measured In
    mg; piece

Pharma Zentrale GmbH

  • DE
  • 2015
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

More Products from Pharma Zentrale GmbH (4)

Pharma Zentrale GmbH resources (2)